A feasible and acceptable logbook system is an attainable goal, although students usually did not complete logbooks unless required. The available literature does not establish that logbooks currently in use have sufficient reliability or validity to allow for the routine use of the information for program change or accreditation purposes. The ideal logbook should be inexpensive, feasible, and acceptable to students and should allow rapid collation of accurate, relevant data for timely analysis and feedback to the student and clerkship director.
The decision to undergo pericardectomy for symptomatic pericardial constriction is usually dictated by an image of an abnormal pericardium. We report a case of symptomatic pericardial constriction despite radiographic and pathological evidence of a normal pericardium. The patient was successfully treated with a pericardectomy, with resolution of constrictive hemodynamics and symptoms. Our report suggests that a normal pericardium by computed tomography and biopsy should not preclude pericardectomy for patients who have refractory symptoms, physical findings, and intracardiac pressures diagnostic of constrictive pericarditis.
INTRODUCTION: Diarrhea is a known common side effect of chemotherapy, and is commonly associated with Capecitabine which was developed to increase systemic tolerability with tumor-specific conversion to 5-FU. Early onset diarrhea and mild to moderate diarrhea have been noted to occur in colorectal cancer patients on Capecitabine. Chemotherapy induced diarrhea (CID) can be life-threatening in severe cases due to resulting electrolyte imbalances, metabolic acidosis, and renal failure. Loperamide is the first line treatment for CID with octreotide being second-line treatment when patients fail to respond to loperamide within 48 hours. However, in cases of severe CID it is recommended that octreotide be initiated as first line therapy. CASE DESCRIPTION/METHODS: A 70 year old male with a history of poorly differentiated mucinous adenocarcinoma of the colon status post capecitabine presented to the ED with complaints of diarrhea. The patient initially presented to the oncology office with reported diarrhea, which was untreated at that time as diarrhea was suspected to be self limiting since he had stopped chemotherapy two days prior. When diarrhea did not abate he was admitted for diarrhea with dehydration. During admission octreotide was initiated since diarrhea did not abate on Imodium and loperamide. One week into admission, the patient developed metabolic acidosis (bicarb 8.6) and minimal resolution of diarrhea while on octreotide. Due to continued soft to loose frequent stools, the patient's octreotide dose was increased to 200 mcg every 8 hours and patient was placed back on scheduled loperamide. He was discharged on 30 mg long acting subcutaneous octreotide and as needed loperamide. He subsequently received 2 additional doses due to continued diarrhea before representing to the ED three months later for worsening diarrhea. DISCUSSION: This case demonstrates the complications that can arise from delayed octreotide treatment in diarrhea status post capecitabine treatment for colon cancer. 5-FU based chemotherapy has been known to result in potentially life-threatening mucosal toxicity. Literature review has shown that octreotide has improved overall response when compared to loperamide in resolution of CID diarrhea. This patient's poor inpatient response to anti-diarrheal agents highlights the importance of early CID management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.